Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • krobison
    Senior Member
    • Nov 2007
    • 734

    #1

    PacBio zips out Haitian cholera genomes

    Pacific Biosciences and a team from Harvard have sequenced 2 isolates from the Haitian cholera outbreak plus 3 reference strains in amazing time -- just over a month from deciding to collaborate to publication in a top journal! Actual sequence generation was 2 days after receipt of the bacterial genomic DNA.

    Good article in BioIT World with the backstory, and currently free on New England Journal of Medicine with the science (paper; supplement with detailed methods).
  • ECO
    --Site Admin--
    • Oct 2007
    • 1360

    #2
    Thanks for posting this Keith.

    Comment

    • Geneus
      Member
      • Dec 2010
      • 60

      #3
      Originally posted by krobison View Post
      Pacific Biosciences and a team from Harvard have sequenced 2 isolates from the Haitian cholera outbreak plus 3 reference strains in amazing time -- just over a month from deciding to collaborate to publication in a top journal! Actual sequence generation was 2 days after receipt of the bacterial genomic DNA.

      Good article in BioIT World with the backstory, and currently free on New England Journal of Medicine with the science (paper; supplement with detailed methods).
      Wow...a little bit of a "bow shot" to Illumina and ABI...I guess it really works.

      Comment

      • microphobe
        Junior Member
        • Sep 2009
        • 7

        #4
        I've been interested in the Pac Bio system because of the long reported read lengths but I've found it difficult to find any reliable stats or raw trace data.

        They quote some highly qualified stats with their system that sound good until you read the fine print, like claiming ~5kb read lengths but only when "strobing" (i.e. not actually recording the majority of the sequence.) and claiming >99.99% accuracy, but for the consensus sequence (i.e. the consensus after aligning dozens of reads, which doesn't say anything about the actual per-read accuracy).

        Pac Bio seem to be very coy about releasing any meaningful stats or raw trace data... Are there any third parties out there who have any hands-on experience with this system and who can verify their claims?

        EDIT: OK I just noticed the supplementary info for that paper, and Table S1 answered a few of my questions... single-pass accuracy was ~82%, mean read length ~1kb (I am assuming they didn't strobe for these reads) with best 5% of reads > 1.8-2.8 kb. The DNA was sheared to ~2kb so I guess they didn't resequence individual clones since as I understand it they would need ~500bp fragments to sequence twice with a read length of 1kb. All in all not bad for 2 day's work, but I'd still like to see some actual traces.

        IMO, the system is still crying out for a photostable polymerase to allow real single-molecule consensus sequencing with long fragments. I hear they are working on it, definitely one to watch.
        Last edited by microphobe; 12-15-2010, 06:49 PM.

        Comment

        • Geneus
          Member
          • Dec 2010
          • 60

          #5
          My understanding is the early adopters of the PacBio systems have been under a type of "gag order" as part of the paid for beta program...or something to that effect.

          Comment

          • krobison
            Senior Member
            • Nov 2007
            • 734

            #6
            If you sign up for their DevNet informatics site, they have some E.coli raw reads there -- but I can't claim to have actually played with them.

            Comment

            • ECO
              --Site Admin--
              • Oct 2007
              • 1360

              #7
              This link has been published before so I don't believe I'm crossing any lines...but the cholera dataset is available in the SRA here:

              ftp://ftp.ncbi.nlm.nih.gov/sra/Submi...026/SRA026766/

              Comment

              • OlivierE
                Junior Member
                • Dec 2010
                • 1

                #8
                In case anybody is interested, I posted a partial re-analysis of their dataset, with a few numbers and observations they don't directly provide in the NEJM paper.

                The first Pacific Biosciences (PacBio) sequence dataset was published a couple of weeks ago in the New England Journal of Medicine. PacBio, together with a Harvard group, sequenced 5 strains of Vib…

                Comment

                • ECO
                  --Site Admin--
                  • Oct 2007
                  • 1360

                  #9
                  Originally posted by OlivierE View Post
                  In case anybody is interested, I posted a partial re-analysis of their dataset, with a few numbers and observations they don't directly provide in the NEJM paper.

                  http://oelemento.wordpress.com/2011/...uence-dataset/
                  Nice first post...!

                  Comment

                  • Joann
                    Senior Member
                    • Oct 2008
                    • 230

                    #10
                    Many thanks for your analysis, the data therein is very helpful/useful.

                    Comment

                    Latest Articles

                    Collapse

                    • SEQadmin2
                      Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
                      by SEQadmin2



                      Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

                      Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
                      ...
                      10-14-2026, 09:55 AM
                    • SEQadmin2
                      New Genomics Technologies Take Aim at Long-Standing Limits
                      by SEQadmin2


                      Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

                      We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
                      ...
                      09-28-2026, 10:25 AM

                    ad_right_rmr

                    Collapse

                    News

                    Collapse

                    Topics Statistics Last Post
                    Started by SEQadmin2, Yesterday, 10:52 AM
                    0 responses
                    9 views
                    0 reactions
                    Last Post SEQadmin2  
                    Started by SEQadmin2, 10-14-2026, 05:39 AM
                    0 responses
                    19 views
                    0 reactions
                    Last Post SEQadmin2  
                    Started by SEQadmin2, 10-13-2026, 09:56 AM
                    0 responses
                    16 views
                    0 reactions
                    Last Post SEQadmin2  
                    Started by SEQadmin2, 10-09-2026, 11:14 AM
                    0 responses
                    27 views
                    0 reactions
                    Last Post SEQadmin2  
                    Working...